Enhanced gene repair mediated by methyl-CpG-modified single-stranded oligonucleotides

Area of Science:

• Molecular Biology
• Genetics
• Biotechnology

Background:

• Oligonucleotide-mediated gene editing enables stable genomic alterations.
• Low gene repair frequencies currently limit its therapeutic and research applications.

Purpose of the Study:

• To investigate methods for enhancing gene correction efficiency using modified single-stranded oligodeoxynucleotides (ssODNs).
• To explore the role of methyl-CpG binding domain protein 4 (MBD4) in the gene correction process.

Main Methods:

• Utilized ssODNs with a methyl-CpG modification designed to bind MBD4.
• Compared gene correction levels with modified and unmodified ssODNs.
• Assessed correction stability through cell division and at protein, transcript, and genomic levels.
• Employed RNA interference (RNAi) to downregulate MBD4 expression and evaluate its impact on correction efficacy.

Main Results:

• Methyl-CpG-modified ssODNs increased gene correction levels more than 10-fold compared to unmodified ssODNs.
• Corrected genes were stably inherited across cell divisions.
• MBD4 downregulation abolished the enhancement in gene correction efficacy, confirming MBD4's specific role.
• Demonstrated that ssODN type and repair mechanism modulation control genomic target manipulation.

Conclusions:

• Engineered ssODNs, particularly those modified with methyl-CpG to engage MBD4, represent a significant advancement in gene editing technology.
• This approach offers a controllable and efficient method for genomic manipulation, surpassing previous limitations.
• The findings hold substantial promise for gene therapy, providing a potential for permanent genetic defect correction.